IRCT2015011920715N1已完成2 期
Effect of oral propranolol on coetaneous hemangioma in children under 15 years of Amir Kabir Hospital
Arak University Of Medical Science0 个研究点目标入组 32 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 32
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 78 years 至 93 years（—）
- 性别
- All
入选标准
- •age under 15 years; numerous Hemangiomas; tumor size greater than 5 cm; Hemangioma on the face and nose. Exclusion criteria: age over 15 years; underlying heart disease; asthma; liver or kidney dysfunction; hypoglycemia; or low blood pressure due to drug use; consent to continue the study; the presence of compression lesion during the period under consideration.
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Evaluation of efficacy of propranolol on hemangioma and lymphangioma.hemangioma, lymphangiomaJPRN-UMIN000004626Kanazawa Medical University Hospital30
已完成
不适用
Oral propranolol therapy for infantile hemangiomasInfantile hemangiomasJPRN-UMIN000007664Tokushima University Hospital30
已完成
不适用
Propranolol therapy for pediatric hemangioma and lymphangiomapediatric hemangioma and lymphangiomaJPRN-UMIN000005990Tohoku University Hospital
已完成
不适用
Propranolol for infantile hemangiomasInfantile hemangiomasJPRN-UMIN000011944Plastic and Reconstructive Surgery, Keio university, School of medicine30
已完成
不适用
Efficacy of proplanorol for infantile hemangiomaInfantile HemangiomaJPRN-UMIN000020220Tohoku University Hospital25